ClinicalTrials.govpublic full text
Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
severe hemophilia a, hemophilia a, plasma-derived treatment, factor viii, inhibitor, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803497
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.